SCHEMBL1223951

SCHEMBL1223951

CCOC([SiH3])(CCC(C)(C)CN)OCC

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL57376 0.77 CYP2D6 (0.41) CYP2D6
SCHEMBL1847271 0.77
SCHEMBL1491903 0.76
SCHEMBL302858 0.73 CYP1A2 (0.31)
SCHEMBL5432822 0.72 CYP2D6 (0.69) CYP2D6
SCHEMBL1845795 0.71 DNM1 (0.35)
SCHEMBL537895 0.71
SCHEMBL19889867 0.68 CYP2D6 (0.53) CYP2D6
SCHEMBL1003396 0.67
SCHEMBL10967603 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137772-B Process for preparing silylated polymers with low color and color stability 莫门蒂夫性能材料股份有限公司 2021-06-29 CN claimed
CN-108012542-B Process for preparing silylated polymers using a back-mixing step 莫门蒂夫性能材料股份有限公司 2021-02-19 CN claimed
EP-2287228-B1 Process for the continuous production of silylated resin MOMENTIVE PERFORMANCE MAT INC (US) 2013-05-08 EP claimed
EP-2287228-A2 Process for the continuous production of silylated resin Momentive Performance Materials Inc. (US) 2011-02-23 EP claimed
US-7435787-B2 Process for the continuous production of silylated resin MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-10-14 US claimed
EP-1940915-A2 PROCESS FOR THE CONTINUOUS PRODUCTION OF SILYLATED RESIN Momentive Performance Materials Inc. (US) 2008-07-09 EP claimed
WO-2007037824-A2 PROCESS FOR THE CONTINUOUS PRODUCTION OF SILYLATED RESIN MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2007-04-05 WO claimed
US-20070060735-A1 Process for the continuous production of silylated resin MOMENTIVE PERFORMANCE MATERIALS INC. 2007-03-15 US claimed
EP-1216263-B1 COMPOSITIONS OF SILYLATED POLYMER AND AMINOSILANE ADHESION PROMOTERS CROMPTON CORP (US) 2003-10-29 EP claimed
EP-1216263-A1 COMPOSITIONS OF SILYLATED POLYMER AND AMINOSILANE ADHESION PROMOTERS Crompton Corporation (US) 2002-06-26 EP claimed
US-6310170-B1 Compositions of silylated polymer and aminosilane adhesion promoters CK WITCO CORPORATION 2001-10-30 US claimed
WO-2001012693-A1 COMPOSITIONS OF SILYLATED POLYMER AND AMINOSILANE ADHESION PROMOTERS CROMPTON CORPORATION (US) 2001-02-22 WO claimed
US-12227531-B2 Silylated organomodified compounds MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2025-02-18 US disclosed
WO-2023096809-A1 SILYLATED ORGANOMODIFIED COMPOUNDS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2023-06-01 WO disclosed
US-20230159571-A1 SILYLATED ORGANOMODIFIED COMPOUNDS MOMENTIVE PERFORMANCE MATERIALS INC. 2023-05-25 US disclosed
EP-3027666-B1 POLYMER CONTAINING SILANE GROUPS SIKA TECH AG (CH) 2021-11-17 EP disclosed
US-20070060735-A1 Process for the continuous production of silylated resin MOMENTIVE PERFORMANCE MATERIALS INC. 2007-03-15 US disclosed
EP-1576031-A1 POLYMER COMPRISING 3-(N-SILYLALKYL)-AMINO-PROPENOATE GROUPS AND USE THEREOF Sika Technology AG (CH) 2005-09-21 EP disclosed
WO-2004056905-A1 POLYMER COMPRISING 3-(N-SILYLALKYL)-AMINO-PROPENOATE GROUPS AND USE THEREOF SIKA TECHNOLOGY AG (CH) 2004-07-08 WO disclosed
EP-1431328-A1 3-(N-Silylalkyl)-amino-propenate-containing polymers and their production Sika Technology AG (CH) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227531-B2 Silylated organomodified compounds SHBG, NR5A1, CYP19A1 CYP2D6 443/4885
US-20230159571-A1 SILYLATED ORGANOMODIFIED COMPOUNDS SHBG, NR5A1, CYP19A1 CYP2D6 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.